32
Participants
Start Date
October 31, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Photobiomodulation therapy (PBM) device
FDA-cleared near-infrared PBM device delivering therapeutic light to the affected knee. Administered once per session, approximately 10 minutes after topical application, in six sessions over 2-3 weeks (2-3 times per week).
Sham PBM device
Identical in appearance to the active PBM device but emits no therapeutic light. Administered once per session, approximately 10 minutes after topical application, in six sessions over 2-3 weeks.
Diclofenac Sodium 1 % Topical Cream
Topical nonsteroidal anti-inflammatory drug applied at a dose of 4 grams to the affected knee, once per session, immediately before PBM/sham PBM. Used in six sessions over 2-3 weeks.
Placebo topical cream
Inert cream matching the appearance of diclofenac sodium 1% gel. Applied at 4 grams to the affected knee, once per session, immediately before PBM/sham PBM. Used in six sessions over 2-3 weeks
University of Florida, Gainesville
University of Florida
OTHER